5VA-10454-70345
1 vaccination
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 658 / MO
- Registered
- 2022-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-02-07
Dose 1 — Pfizer-BioNTech
-
2022-02-11
Registered in v-safe
- 2022-02-11
- 2022-02-12
- 2022-02-14
-
2022-02-21
Survey response — day 14, dose 1MedDRA: Asthenia, Back pain, Chills, Dizziness, Fatigue, Headache, Ocular discomfort, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 2/19/22 I started chilling, running high fever, back pain, headache, dizziness, eye pressure, and debilitating fatigue.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-02-07 | Pfizer-BioNTech | No |
Free text
Release 11 — day 14, dose 1
Symptoms: 2/19/22 I started chilling, running high fever, back pain, headache, dizziness, eye pressure, and debilitating fatigue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Ocular discomfort | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release